nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
17-AAG, an Hsp90 Inhibitor, Suppress Hepatitis C Virus (HCV) Replication
|
Ujino, Saneyuki |
|
2007 |
74 |
3 |
p. A62-A63 nvt p. |
artikel |
2 |
Activation of GS-7340 and Other Tenofovir Phosphonoamidate Prodrugs by Human Proteases
|
Birkus, Gabriel |
|
2007 |
74 |
3 |
p. A57- 1 p. |
artikel |
3 |
A High Throughput HIV-1 Full Replication Assay that Includes HIV-1 Vif as an Antiviral Target
|
Cao, Joan |
|
2007 |
74 |
3 |
p. A64-A65 nvt p. |
artikel |
4 |
An Animal Model of HCMV Infection in SCID Mice
|
Bravo, Fernando |
|
2007 |
74 |
3 |
p. A69- 1 p. |
artikel |
5 |
A Novel Class of Amphipathic DNA Polymers Inhibits Hepatitis C Virus Infection by Blocking Viral Entry
|
Matsumura, Takuya |
|
2007 |
74 |
3 |
p. A60- 1 p. |
artikel |
6 |
Anti-HBV Nucleotide Prodrug Analogs: Synthesis, Bioreversibility, and Cytotoxicity Studies
|
Padmanabhan, Seetharamaiyer |
|
2007 |
74 |
3 |
p. A89- 1 p. |
artikel |
7 |
Anti-Influenza A Synergistic Combination Effect of Rimantadine and Oseltamivir in Mice
|
Simeonova, Lora |
|
2007 |
74 |
3 |
p. A46-A47 nvt p. |
artikel |
8 |
Anti-orthopoxviral Activity of the 2-Cycloalkylimino-5-(4-Nitrophenyl)-1,3,4-Thiadiazines
|
Belanov, Evgeny |
|
2007 |
74 |
3 |
p. A77- 1 p. |
artikel |
9 |
Antiviral Activities of New Cidofovir Analogs Against Camelpox Virus, Used as a Model of Variola Virus, in Human Skin Equivalent Cultures
|
Duraffour, Sophie |
|
2007 |
74 |
3 |
p. A78- 1 p. |
artikel |
10 |
Antiviral Activity of (−)-Carbocyclic Cytosine [(−)-Carbodine] Against Venezuelan Equine Encephalitis Virus (VEEV) in a Mouse Model
|
Julander, Justin |
|
2007 |
74 |
3 |
p. A44-A45 nvt p. |
artikel |
11 |
Antiviral Activity of Reverse Transcriptase Inhibitors against Porcine Endogenous Retroviruses (PERV)
|
Shi, Minyi |
|
2007 |
74 |
3 |
p. A62- 1 p. |
artikel |
12 |
A Rapid DNA Hybridization Assay for the Evaluation of Antiviral Compounds Against Epstein-Barr Virus
|
Prichard, Mark |
|
2007 |
74 |
3 |
p. A81- 1 p. |
artikel |
13 |
Benzimidazole with Broad Spectrum of Antiviral Action
|
Lozytska, Regina |
|
2007 |
74 |
3 |
p. A80- 1 p. |
artikel |
14 |
Bile Acid Conjugates Improve the Oral Bioavailability of the Neurominidase Inhibitor Zanamivir
|
Kish, Phillip |
|
2007 |
74 |
3 |
p. A45-A46 nvt p. |
artikel |
15 |
Brivudin (ZostexR) in the Treatment of Herpes Zoster in Immunosuppressed Patients
|
Meerbach, Astrid |
|
2007 |
74 |
3 |
p. A75- 1 p. |
artikel |
16 |
Carbohydrate-Binding Agents (CBAs) Potently Inhibit HIV Infection In Human Primary Monocytes/Macrophages and Efficiently Prevent Viral Capture and Subsequent Transmission to CD+4 T Lymphocytes
|
Pollicita, Michela |
|
2007 |
74 |
3 |
p. A55-A56 nvt p. |
artikel |
17 |
Carbohydrate-Binding Agents (CBAs) Selectively Target the Glycoproteins of the HCV and HIV Envelope to Prevent Viral Entry
|
Balzarini, J. |
|
2007 |
74 |
3 |
p. A43- 1 p. |
artikel |
18 |
Characterization of a New Class of Polycyclic RSV Inhibitors
|
Luttick, Angela |
|
2007 |
74 |
3 |
p. A66- 1 p. |
artikel |
19 |
Characterization of Influenza Virus Clinical Isolates Obtained During Clinical Study of Arbidol
|
Leneva, Irina |
|
2007 |
74 |
3 |
p. A55- 1 p. |
artikel |
20 |
Characterization of the Intracellular Metabolism of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyl-Cytidine and the Inhibition of HCV Polymerase NS5B by its 5′-Triphosphate Species
|
Ma, Han |
|
2007 |
74 |
3 |
p. A36- 1 p. |
artikel |
21 |
Chemical Stability and Intracellular Metabolism of 1-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]-5-Azacytosine
|
Naesens, Lieve |
|
2007 |
74 |
3 |
p. A86- 1 p. |
artikel |
22 |
Chloroquine a Novel and Versatile Anti viral Agent with Nine Prong Modes of Anti viral Actions and Postive Approach in Radical Cure of Viral Hepatitis Varieties B and C Both Acute and Chronic Forms
|
Chandramohan, M. |
|
2007 |
74 |
3 |
p. A74-A75 nvt p. |
artikel |
23 |
Combinations of CMX-001 and ST-246 Synergistically Inhibit Orthopoxvirus Replication In Vitro
|
Keith, Kathy |
|
2007 |
74 |
3 |
p. A79-A80 nvt p. |
artikel |
24 |
Combinations of Thiovir and Neuraminidase Inhibitors Exert Synergistic Antiviral Activity on Human, Equine and Avian Influenza In Vitro
|
Waninger, Shani |
|
2007 |
74 |
3 |
p. A82- 1 p. |
artikel |
25 |
Combined Anti-Influenza Virus Effect of a Plant Polyphenol-Rich Extract and Ribavirin
|
Serkedjieva, Julia |
|
2007 |
74 |
3 |
p. A46- 1 p. |
artikel |
26 |
Comparative Activity of Anti-Enteroviral Agents Against Poliovirus Replication In Vitro
|
De Palma, Armando M. |
|
2007 |
74 |
3 |
p. A43- 1 p. |
artikel |
27 |
Comparison of Anti-Proliferative Activity of Selected Antiviral Agents in Various Assay Systems
|
Hartline, Caroll |
|
2007 |
74 |
3 |
p. A78-A79 nvt p. |
artikel |
28 |
Contents of Volume
|
|
|
2007 |
74 |
3 |
p. A98-A99 nvt p. |
artikel |
29 |
Crosstalk Between Scavenger Receptors (SR-A) and Toll-like Receptors (TLR) Results in Rapid Pro-Inflammatory Cytokine Differentiation in Monocytes Exposed to Cytomegalovirus (CMV)
|
Yew, Hooi |
|
2007 |
74 |
3 |
p. A88- 1 p. |
artikel |
30 |
Cytopathic Maporal Hantavirus Infection of Vero E6 Cells
|
Gowen, Brian |
|
2007 |
74 |
3 |
p. A78- 1 p. |
artikel |
31 |
DC-SIGN is Not Required for HIV-1 Transmission to CD4+ T Lymphocytes
|
Clotet-Codina, Imma |
|
2007 |
74 |
3 |
p. A65- 1 p. |
artikel |
32 |
7-Deaza Neplanocin Analogs Inhibit Hepatitis C Virus (HCV) in Vitro
|
Kim, H.J. |
|
2007 |
74 |
3 |
p. A49- 1 p. |
artikel |
33 |
Design and Cellular Kinetics of Dansyl-labeled CADA Derivatives with Specific Anti-HIV and CD4 Receptor Down-modulating Properties
|
Vermeire, Kurt |
|
2007 |
74 |
3 |
p. A68-A69 nvt p. |
artikel |
34 |
Design and Characterization of R1626, A Prodrug of the HCV Replication Inhibitor R1479 (4′-Azidocytidine) With Enhanced Oral Bioavailability
|
Klumpp, Klaus |
|
2007 |
74 |
3 |
p. A35- 1 p. |
artikel |
35 |
Design and Synthesis of Novel Anti-HCMV Agents: Modifications to the Bicyclic Pyrimidine Base
|
Adak, Rina |
|
2007 |
74 |
3 |
p. A71- 1 p. |
artikel |
36 |
Design, Synthesis and Anti-HIV Activity of Some Novel Isatin Derivatives
|
Selvam, Periyasamy |
|
2007 |
74 |
3 |
p. A68- 1 p. |
artikel |
37 |
Design, Synthesis, and Biological Evaluation of Novel Anti-VZV Agents
|
Derudas, Marco |
|
2007 |
74 |
3 |
p. A72- 1 p. |
artikel |
38 |
Design, Synthesis, Anti-HIV and Cytotoxicity of Novel Heterocyclic Compounds
|
Selvam, Periyasamy |
|
2007 |
74 |
3 |
p. A51- 1 p. |
artikel |
39 |
Design, Synthesis, Antiviral Activity and Cytotoxicity of Novel Sulphonamide Derivatives
|
Selvam, P. |
|
2007 |
74 |
3 |
p. A81- 1 p. |
artikel |
40 |
Development and Validation of a High Throughput Screen for Inhibitors of Respiratory Syncytial Virus
|
Heil, Marintha |
|
2007 |
74 |
3 |
p. A59- 1 p. |
artikel |
41 |
Development of a Cell-Based Assay for Identification of Viral Entry Inhibitors Against SARS-CoV by High Throughput Screening (HTS)
|
Zhang, Chengsheng |
|
2007 |
74 |
3 |
p. A82- 1 p. |
artikel |
42 |
Development of Anti-Infective Topical Microbicides
|
Watson, Karen |
|
2007 |
74 |
3 |
p. A64- 1 p. |
artikel |
43 |
Development of Anti-Infective Topical Microbicides
|
Watson, Karen |
|
2007 |
74 |
3 |
p. A63- 1 p. |
artikel |
44 |
Development of Anti-Infective Topical Microbicides
|
Watson, Karen |
|
2007 |
74 |
3 |
p. A63- 1 p. |
artikel |
45 |
Development of ATP/Luminescence Assays For Profiling Compounds Against A Panel of Positive-Strand RNA Viruses
|
Gong, Edwin |
|
2007 |
74 |
3 |
p. A58- 1 p. |
artikel |
46 |
Development of Hepatitis C Virus (HCV) Chimeric Replicons for Identifying Broad Spectrum NS3 Protease Inhibitors
|
Binder, Joseph |
|
2007 |
74 |
3 |
p. A38- 1 p. |
artikel |
47 |
Development of Intergenotypic Chimeric Replicons for Broad-spectrum Antiviral Activity Characterization of Hepatitis C Virus Polymerase Inhibitors
|
Herlihy, Koleen |
|
2007 |
74 |
3 |
p. A59- 1 p. |
artikel |
48 |
Development of Novel Cell Lines for the Detection and Quantification of Herpesvirus Replication
|
Binford, Susan |
|
2007 |
74 |
3 |
p. A77- 1 p. |
artikel |
49 |
Discovery of a New Class of Polycyclic RSV Inhibitors
|
Bond, Silas |
|
2007 |
74 |
3 |
p. A30- 1 p. |
artikel |
50 |
Discovery of Cage Antiviral Agents
|
Klimochkin, Yuri |
|
2007 |
74 |
3 |
p. A73- 1 p. |
artikel |
51 |
Discovery of Novel Small Molecule Inhibitors of Dengue Virus Replication
|
Byrd, Chelsea |
|
2007 |
74 |
3 |
p. A77- 1 p. |
artikel |
52 |
Discovery of Two Novel Classes of Inhibitors of Hepatitis C Virus (HCV) Replication utilizing a Dicistronic Reporter HCV Replicon High Throughput Assay
|
Hao, Weidong |
|
2007 |
74 |
3 |
p. A58- 1 p. |
artikel |
53 |
Drug Resistance to Tipranavir (TPV) or Darunavir (DRV) According to New Interpretation Algorithms in PI-naïve HIV-1 Infected Patients
|
Stuermer, M. |
|
2007 |
74 |
3 |
p. A29- 1 p. |
artikel |
54 |
Editorial Board
|
|
|
2007 |
74 |
3 |
p. ii- 1 p. |
artikel |
55 |
Efficacy of Cationic Lipid-DNA Complexes (CLDC) on Hepatitis B Virus in Transgenic Mice
|
Morrey, John D. |
|
2007 |
74 |
3 |
p. A40- 1 p. |
artikel |
56 |
Efficacy of Delayed Therapy Using Combinations of ST-246 with CMX-001 Against Systemic Cowpox Virus Infections in Mice
|
Quenelle, Debra |
|
2007 |
74 |
3 |
p. A70- 1 p. |
artikel |
57 |
Efficacy of 5-Halogenated 2′-Deoxyuridines on Vaccinia Virus Thymidine Kinase Positive and Negative Strains, and Influence of Cell Type on Antiviral Potency
|
Smee, Donald |
|
2007 |
74 |
3 |
p. A87- 1 p. |
artikel |
58 |
Efficacy of Oral CMX-001 Therapy Against Human Herpes Virus-6 Infections in SCID-hu Mice
|
Quenelle, Debra |
|
2007 |
74 |
3 |
p. A70- 1 p. |
artikel |
59 |
Enhanced Antiviral Activity of Hexadecyloxypropyl-PME-N 6-Cyclopropyl-diaminopurine Against Herpesviruses, Hepatitis B Virus and Vaccinia Virus, In Vitro
|
Andrei, Graciela |
|
2007 |
74 |
3 |
p. A76- 1 p. |
artikel |
60 |
Enhanced Potency and Efficacy of 29-mer shRNAs in Inhibition of Enterovirus 71
|
Tan, Eng-Lee |
|
2007 |
74 |
3 |
p. A87-A88 nvt p. |
artikel |
61 |
Evidence For In Vivo Inhibition of CMV Infection by the Quinazoline Class Protein Kinase Inhibitor Gefitinib
|
Schleiss, Mark |
|
2007 |
74 |
3 |
p. A34-A35 nvt p. |
artikel |
62 |
Fractal Microscope—Multipurpose Device For Antiviral Research
|
Fedchuk, Oleksandr |
|
2007 |
74 |
3 |
p. A53-A54 nvt p. |
artikel |
63 |
Full Author Index—Abstract Number
|
|
|
2007 |
74 |
3 |
p. A90-A95 nvt p. |
artikel |
64 |
Future Conferences
|
|
|
2007 |
74 |
3 |
p. A97- 1 p. |
artikel |
65 |
Generation and Characterization of Fully Human Antibodies Against Orthopoxviruses
|
Yun, Tatynana |
|
2007 |
74 |
3 |
p. A56- 1 p. |
artikel |
66 |
GL59728: A Potent Allosteric Inhibitor of the HCV NS5b RNA Dependent RNA Polymerase with Excellent Pharmacokinetic Properties
|
Roberts, Christopher |
|
2007 |
74 |
3 |
p. A37- 1 p. |
artikel |
67 |
GS-8374, a Novel Phosphonate HIV Protease Inhibitor with Potent In Vitro Antiretroviral Activity, Low Metabolic Toxicity, and Favorable Resistance Profile
|
Callebaut, Christian |
|
2007 |
74 |
3 |
p. A27- 1 p. |
artikel |
68 |
High Throughput Screening of a 100,000 Compound Library for Inhibitors of Influenza A Virus (H3N2)
|
Severson, William |
|
2007 |
74 |
3 |
p. A62- 1 p. |
artikel |
69 |
HINT as Putative Phosphoramidase Responsible of ProTides Activation: Molecular Modelling Studies
|
Congiatu, Costantino |
|
2007 |
74 |
3 |
p. A71- 1 p. |
artikel |
70 |
HIV Coreceptor Switch Induced by Antagonism to CCR5
|
Moncunill, Gemma |
|
2007 |
74 |
3 |
p. A66-A67 nvt p. |
artikel |
71 |
HIV Interactions With Other Viruses Determine Pathogenesis in Human Lymphoid Tissues
|
Margolis, Leonid |
|
2007 |
74 |
3 |
p. A29-A30 nvt p. |
artikel |
72 |
HIV-1 Resistance to the Anti-HIV Activity of a siRNA Targeting Rev
|
Senserrich, Jordi |
|
2007 |
74 |
3 |
p. A68- 1 p. |
artikel |
73 |
Human Immunodeficiency Virus Type 1 Does Not Escape from Novel Single-Stranded Dnazyme Expression-Mediated Inhibition
|
Hyafune, Masaak |
|
2007 |
74 |
3 |
p. A66- 1 p. |
artikel |
74 |
Identification and Biochemical Characterization of Small Molecule Inhibitors of West Nile Virus Serine Protease by a High Throughput Screen
|
Padmanabhan, Radhakris |
|
2007 |
74 |
3 |
p. A30- 1 p. |
artikel |
75 |
Identification and Characterization of a Novel, Potent HCV Helicase Inhibitor
|
Peng, Junzhong |
|
2007 |
74 |
3 |
p. A67- 1 p. |
artikel |
76 |
Identification of a Novel Small Molecule Inhibitor that Targets HIV-1 Envelope Maturation
|
Jimenez, Judith |
|
2007 |
74 |
3 |
p. A27- 1 p. |
artikel |
77 |
Identification of Novel Low Molecular Weight HIV-1 gp41 Fusion Inhibitors Using A New Quantitative High Throughput Fluorescence Intensity Assay
|
Gochin, Miriam |
|
2007 |
74 |
3 |
p. A57-A58 nvt p. |
artikel |
78 |
Induction of IL-6 and IL-8 by siRNAs Targeting HIV Correceptor CCR5
|
Pauls, Eduardo |
|
2007 |
74 |
3 |
p. A67- 1 p. |
artikel |
79 |
Influence of Substitutes in the Central Phenyl Ring of Capsid Function Inhibitors on Anti-coxsackievirus B3 Activity
|
Schmidtke, Michaela |
|
2007 |
74 |
3 |
p. A86- 1 p. |
artikel |
80 |
Inhibition of an Innate Antiviral Response by Human Cytomegalovirus UL97 Kinase is Antagonized by Maribavir
|
Prichard, Mark |
|
2007 |
74 |
3 |
p. A41-A42 nvt p. |
artikel |
81 |
Inhibition of Cellular Entry and Spread of Lymphocytic Choriomeningitis Virus by Amphipathic DNA Polymers
|
Lee, Andrew |
|
2007 |
74 |
3 |
p. A80- 1 p. |
artikel |
82 |
Inhibition of the Tax-Dependent Human T-Lymphotropic Virus Type 1 (HTLV-1) Replication in Persistently Infected Cells by the Naphthalene Derivative JTK-101
|
Wang, Xin |
|
2007 |
74 |
3 |
p. A81- 1 p. |
artikel |
83 |
Initial Pharmacodynamic Evaluation of Orally Bioavailable Prodrugs of SB-9000, a Novel Anti-HBV Agent
|
Iyer, Radhakrishnan |
|
2007 |
74 |
3 |
p. A54-A55 nvt p. |
artikel |
84 |
Intracellular Localization of Herpes Simplex Virus Type 1 Thymidine Kinase in Cells Infected with Various Thymidine Kinase-Deficient Viruses
|
Lee, Chong-Kyo |
|
2007 |
74 |
3 |
p. A85- 1 p. |
artikel |
85 |
Intramuscular Administration of Neuraminidase Inhibitor Peramivir Promotes Survival Against Lethal H5N1 Influenza Infection in Mice
|
Boltz, David A. |
|
2007 |
74 |
3 |
p. A32- 1 p. |
artikel |
86 |
Intranasal Protollin Formulated Recombinant SARS-CoV S Protein Elicits Respiratory and Serum Neutralizing Antibodies
|
Barnard, Dale |
|
2007 |
74 |
3 |
p. A45- 1 p. |
artikel |
87 |
Invitation to the Twenty-first International Conference on Antiviral Research
|
|
|
2007 |
74 |
3 |
p. A96- 1 p. |
artikel |
88 |
In Vitro and In Vivo Activity of T-705 Against Arenavirus and Bunyavirus Infections
|
Jung, Kie-Hoon |
|
2007 |
74 |
3 |
p. A44- 1 p. |
artikel |
89 |
In Vivo Antiviral Activity of 1-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]-5-Azacytosine and its Cyclic Form
|
Andrei, Graciela |
|
2007 |
74 |
3 |
p. A33-A34 nvt p. |
artikel |
90 |
Involvement of New Mutational Pattern in HIV-1 gp41 in T-20 Treatment
|
Aquaro, Stefano |
|
2007 |
74 |
3 |
p. A28-A29 nvt p. |
artikel |
91 |
Isolation and Characterization of an Helicase-Primase Inhibitor (HPI)-Resistant HSV-1 Mutant in Tissue Culture and a Mouse-Skin Model
|
Biswas, Subhajit |
|
2007 |
74 |
3 |
p. A34- 1 p. |
artikel |
92 |
JuvImmune is a Novel Vaccine Adjuvant that Enhances Protection of Mice from Lethal HSV-2 Infection Following Immunization
|
Strasser, Jane |
|
2007 |
74 |
3 |
p. A42- 1 p. |
artikel |
93 |
Lymphocytic Necrosis in Hamsters Inoculated with Western Equine Encephalitis Virus
|
Olsen, Aaron |
|
2007 |
74 |
3 |
p. A46- 1 p. |
artikel |
94 |
Metabolism and Pharmacokinetic Studies of SB-9000—A Novel Anti-HBV agent
|
Coughlin, John |
|
2007 |
74 |
3 |
p. A52- 1 p. |
artikel |
95 |
Molecular Design of Active Antiherpetic Compounds Using Hierarchic QSAR Technology
|
Artemenko, A. |
|
2007 |
74 |
3 |
p. A76- 1 p. |
artikel |
96 |
Mononuclear Cells as a Transfer Vehicle For Herpes Simplex Virus (HSV) or Vaccinia Virus (VV) Infection of Epithelial Cells Grown in 3D
|
Andrei, Graciela |
|
2007 |
74 |
3 |
p. A40-A41 nvt p. |
artikel |
97 |
Mutations in the RNaseH Region Observed in the HIV-1 of Antiretroviral Treatment (ART) Experienced Patients
|
Waters, J. |
|
2007 |
74 |
3 |
p. A28- 1 p. |
artikel |
98 |
Neutralizing Human Antibodies From Immune Phage Display Antibody Library Recognize p35 Orthopoxvirus Protein
|
Dubrovskaya, Viktoriya |
|
2007 |
74 |
3 |
p. A53- 1 p. |
artikel |
99 |
New Digital Method of Virus-Cell Interaction Description
|
Fedchuk, Andriy |
|
2007 |
74 |
3 |
p. A53- 1 p. |
artikel |
100 |
New Ribonucleosides with Surrogate Bases: Synthesis, Enzymology, Molecular Docking Studies and Antiviral Activity
|
Nair, Vasu |
|
2007 |
74 |
3 |
p. A74- 1 p. |
artikel |
101 |
NIM811, A Cyclophilin Inhibitor, and NM107, An HCV Polymerase Inhibitor, Synergistically Inhibits HCV Replication and Suppresses the Emergence of Resistance In Vitro
|
Boerner, Joanna |
|
2007 |
74 |
3 |
p. A57- 1 p. |
artikel |
102 |
Nitazoxanide is an Effective Antiviral Agent Against Both HBV and HCV replication in vitro
|
Korba, Brent |
|
2007 |
74 |
3 |
p. A40- 1 p. |
artikel |
103 |
Notes to Authors
|
|
|
2007 |
74 |
3 |
p. CO3- 1 p. |
artikel |
104 |
Novel 4′-Azido-2′-Deoxy-Nucleoside Analogs are Potent Inhibitors of NS5B-Dependent HCV Replication
|
Smith, David |
|
2007 |
74 |
3 |
p. A36- 1 p. |
artikel |
105 |
Novel Diketo Phosphonic Acids Constructed on Nucleobase Scaffolds: Design, Synthesis, Molecular Modeling and Anti-HIV Activity
|
Nair, Vasu |
|
2007 |
74 |
3 |
p. A50- 1 p. |
artikel |
106 |
Novel Synthetic Approaches to Cidofovir and Foscarnet Prodrugs
|
Peterson, Larryn W. |
|
2007 |
74 |
3 |
p. A74- 1 p. |
artikel |
107 |
Nucleosidic Fusion Inhibitors
|
St. Vincent, M. |
|
2007 |
74 |
3 |
p. A87- 1 p. |
artikel |
108 |
Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice
|
Ilyushina, Natalia A. |
|
2007 |
74 |
3 |
p. A31-A32 nvt p. |
artikel |
109 |
Peptidomimetic Dimerization Inhibitors of HIV-1 Protease: Further Insights into Structural Variations and Mechanism of Action
|
Bannwarth, Ludovic |
|
2007 |
74 |
3 |
p. A64- 1 p. |
artikel |
110 |
Pharmacodynamics of NPI-5291, an Adamantane Class Compound, for Influenza A Viruses
|
McSharry, James |
|
2007 |
74 |
3 |
p. A61- 1 p. |
artikel |
111 |
Phosphorodiamidate Morpholino Oligomer—Mediated Inhibition of Influenza A Virus in Mice
|
Voss, Thomas |
|
2007 |
74 |
3 |
p. A47- 1 p. |
artikel |
112 |
Poly-Cooperation of Ionic and Non-Ionic Antiviral Vectors
|
Serbin, A. |
|
2007 |
74 |
3 |
p. A51- 1 p. |
artikel |
113 |
Potent HCV NS5B Polymerase Inhibitors Derived From 5-Hydroxy-3(2H)-Pyridazinones: Part 2
|
Zhou, Y. |
|
2007 |
74 |
3 |
p. A51-A52 nvt p. |
artikel |
114 |
Potent HCV NS5B Polymerase Inhibitors Derived From 5-Hydroxy-3(2H)-Pyridazinones: Part 1
|
Zhou, Y. |
|
2007 |
74 |
3 |
p. A38- 1 p. |
artikel |
115 |
Potent Inhibition of Viral Entry and Replication of SARS-CoV by siRNAs Targeting the Genes Encoding the Cellular ACE2 Receptor or the Viral Nucleocapsid Protein
|
Yan, Xin |
|
2007 |
74 |
3 |
p. A30-A31 nvt p. |
artikel |
116 |
Practical Synthesis of (−)-Carbocyclic Cytosine (Carbodine) and its In Vitro Antiviral Activity against Venezuelan Equine Encephalitis (VEE) Virus and Yellow Fever Virus
|
Rao, J.R. |
|
2007 |
74 |
3 |
p. A47- 1 p. |
artikel |
117 |
Preclinical Development of A New Class of Orally Active Drug Candidates for the Treatment of RSV Infections
|
Luttick, Angela |
|
2007 |
74 |
3 |
p. A55- 1 p. |
artikel |
118 |
Properties of Aminoacid Esters Linked to Cyclo Sal-Pronucleotides
|
Jessen, Henning |
|
2007 |
74 |
3 |
p. A73- 1 p. |
artikel |
119 |
Proteflasid as Inhibitor of EBV-infection
|
Nesterova, N. |
|
2007 |
74 |
3 |
p. A75- 1 p. |
artikel |
120 |
Pyrimidine Nucleosides Containing 5-Substituent: Synthesis and Antiviral Activity
|
Korkach, Stanislav V. |
|
2007 |
74 |
3 |
p. A73- 1 p. |
artikel |
121 |
QSAR Analysis of Anti-Coxsackievirus B3 Nancy Activity of 2-Amino-3-Nitropyrazole[1,5-α]Pyrimidines by Means of Simplex Approach
|
Kuz’min, V. |
|
2007 |
74 |
3 |
p. A49-A50 nvt p. |
artikel |
122 |
QSAR Studies On [(Biphenyloxy)propyl]isoxazole Derivatives With Anti-rhinovirus 2 Activity
|
Muratov, E. |
|
2007 |
74 |
3 |
p. A44- 1 p. |
artikel |
123 |
Raft-tropic Antivirals: 1
|
Egorov, Y. |
|
2007 |
74 |
3 |
p. A49- 1 p. |
artikel |
124 |
Selection of Human Cytomegalovirus Resistant to a Second Generation Methylenecyclopropane Purine
|
Borysko, Katherine Z. |
|
2007 |
74 |
3 |
p. A83-A84 nvt p. |
artikel |
125 |
Selective Phosphorylation of Antiviral Drugs by Vaccinia Virus Thymidine Kinase
|
Harden, Emma |
|
2007 |
74 |
3 |
p. A84-A85 nvt p. |
artikel |
126 |
shRNAs Targeting Hepatitis C: Effects of Sequence and Structural Features, and Comparison with siRNA
|
Johnston, Brian |
|
2007 |
74 |
3 |
p. A59-A60 nvt p. |
artikel |
127 |
Solid-phase synthesis of the anti-HBV dinucleotide SB 9000—Microwave-assisted Functionalization of Solid Supports
|
Padmanabhan, Seetharamaiyer |
|
2007 |
74 |
3 |
p. A88- 1 p. |
artikel |
128 |
Structural Basis for the Expanded Substrate Specificity of Vaccinia Virus Thymidine Kinase: Insight from the Crystal Structure
|
Prichard, Mark |
|
2007 |
74 |
3 |
p. A41- 1 p. |
artikel |
129 |
Sublingual Delivery of SB 9000—An Anti-HBV Dinucleoside Phosphorothioate Analog
|
Iyer, Radhakrishnan |
|
2007 |
74 |
3 |
p. A54- 1 p. |
artikel |
130 |
Sub Micromolar Inhibitors of HCV Generated from Inactive Nucleosides by Application of ProTide Technology
|
McGuigan, Christopher |
|
2007 |
74 |
3 |
p. A36-A37 nvt p. |
artikel |
131 |
Substituted Imidazopyridines as Potent Inhibitors of Hepatitis C Virus Replication that Target the Viral Polymerase
|
Vliegen, Inge |
|
2007 |
74 |
3 |
p. A37- 1 p. |
artikel |
132 |
Substrate Specificity and Molecular Modelling of Feline Herpesvirus-1 Thymidine Kinase
|
Mohammad, Islam |
|
2007 |
74 |
3 |
p. A85- 1 p. |
artikel |
133 |
Successful Treatment in the Monkeypox and Variola Primate Models of Smallpox by the Oral Drug ST-246
|
Huggins, John |
|
2007 |
74 |
3 |
p. A35- 1 p. |
artikel |
134 |
Susceptibility of German Porcine H3N2 Influenza A viruses Against Existing Antiviral Drugs
|
Bauer, Katja |
|
2007 |
74 |
3 |
p. A56-A57 nvt p. |
artikel |
135 |
Synthesis and Anti-HBV Activity of 7-Deaza-Neplanocin A Analogs
|
Kim, Hyo-Joong |
|
2007 |
74 |
3 |
p. A60- 1 p. |
artikel |
136 |
Synthesis and Antiviral Activity of 1-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]-5-Azacytosine and its Ester Prodrugs
|
Krecmerova, Marcela |
|
2007 |
74 |
3 |
p. A33- 1 p. |
artikel |
137 |
Synthesis and Antiviral Evaluation of Iso-methyl-alkoxyalkyl (S)-HPMPA Esters
|
Beadle, James R. |
|
2007 |
74 |
3 |
p. A48- 1 p. |
artikel |
138 |
Synthesis and Properties of Chiral Open-Ring Acyclic Nucleoside Bisphosphonates
|
Doláková, Petra |
|
2007 |
74 |
3 |
p. A72- 1 p. |
artikel |
139 |
Synthesis and Structure–Activity Aspects of Some Cyclic Cidofovir Peptidomimetic Prodrugs
|
Peterson, Larryn W. |
|
2007 |
74 |
3 |
p. A33- 1 p. |
artikel |
140 |
Synthesis and Structure Activity Relationships among Non-nucleoside Analogs of Toyocamycin Active against Herpesviruses
|
Hinkley, Jack M. |
|
2007 |
74 |
3 |
p. A79- 1 p. |
artikel |
141 |
Synthesis, Anti-HIV and CD4 Down-Modulation Activities of Novel CADA Compounds
|
Anugu, Sreenivasa |
|
2007 |
74 |
3 |
p. A48- 1 p. |
artikel |
142 |
Synthesis of Novel Types of Anti-Coxsackie Virus Compounds
|
Šála, Michal |
|
2007 |
74 |
3 |
p. A52- 1 p. |
artikel |
143 |
The Combination of Anti-poxvirus Compounds ST-246 and TTP-018 are Synergistic In Vitro
|
Chen, Yali |
|
2007 |
74 |
3 |
p. A84- 1 p. |
artikel |
144 |
The CXCR4 Antagonist POL3026 is a Potent Inhibitor of Human Immunodeficiency Virus
|
Moncunill, Gemma |
|
2007 |
74 |
3 |
p. A28- 1 p. |
artikel |
145 |
The Cyclophilin Inhibitor Debio-025 is a Potent Inhibitor of Hepatitis C Virus Replication in vitro With a Unique Resistance Profile
|
Coelmont, Lotte |
|
2007 |
74 |
3 |
p. A39- 1 p. |
artikel |
146 |
The Design, Synthesis and Anti-HIV Activity of a Selected Group of 2′,3′-Didehydro-2′,3′-Dideoxyguanosine (d4G) and 2′,3′-Dideoxyguanosine (ddG) ‘ProTide’ Derivatives
|
Mehellou, Youcef |
|
2007 |
74 |
3 |
p. A50- 1 p. |
artikel |
147 |
The Imidazopyrrolopyridine Analogue AG110 is a Novel, Highly Selective Inhibitor of Pestivirus Replication and Targets the viral RNA-dependent RNA Polymerase
|
Paeshuyse, Jan |
|
2007 |
74 |
3 |
p. A39- 1 p. |
artikel |
148 |
The Inhibitory Effects of Medicinal Herbs on SARS-CoV Entry In Vitro
|
Zhuang, Min |
|
2007 |
74 |
3 |
p. A82-A83 nvt p. |
artikel |
149 |
The Triple Combination of Tenofovir, Emtricitabine and Efavirenz Shows Synergistic Anti-HIV-1 Activity In Vitro
|
Myrick, F. |
|
2007 |
74 |
3 |
p. A61- 1 p. |
artikel |
150 |
The Twentieth International Conference on Antiviral Research
|
|
|
2007 |
74 |
3 |
p. A1-A26 nvt p. |
artikel |
151 |
The Virtues of Unique Ribonucleotide Reductase Inhibitors Didox and Trimidox for Retrovirus Therapy
|
Elford, Howard |
|
2007 |
74 |
3 |
p. A65-A66 nvt p. |
artikel |
152 |
Thiazolides: A New Class of Broad-Spectrum Antiviral Drugs Targeting Virus Maturation
|
Santoro, M. Gabriella |
|
2007 |
74 |
3 |
p. A31- 1 p. |
artikel |
153 |
Thiazolobenzimidazoles, a Novel Class of Enterovirus Inhibitors, Target the 2C Protein
|
De Palma, Armando M. |
|
2007 |
74 |
3 |
p. A84- 1 p. |
artikel |
154 |
Treatment of Paralysis Caused by West Nile Virus in Hamsters
|
Morrey, John D. |
|
2007 |
74 |
3 |
p. A32- 1 p. |
artikel |
155 |
Uptake and Metabolism of Cidofovir and Oleyloxyethyl-cidofovir in Human Papillomavirus Positive ME-180 Human Cervical Cancer Cells
|
Aldern, Kathy A. |
|
2007 |
74 |
3 |
p. A83- 1 p. |
artikel |
156 |
Use of CpG DNA in Co-administration with Cidofovir or Monoclonal Antibody as a Post Exposure Antiviral Therapy
|
Phelps, Amanda |
|
2007 |
74 |
3 |
p. A69-A70 nvt p. |
artikel |
157 |
Vaccination as an Antiviral Strategy for Control of Cytomegalovirus (CMV) Disease: A Vectored Vaccine Approach Targeting the UL83 (pp65) Homolog Protects Against Congenital CMV Disease in the Guinea Pig Model
|
Schleiss, Mark |
|
2007 |
74 |
3 |
p. A42- 1 p. |
artikel |